Earnings Call · Q2 FY2022·2022-07-27

Q2 22EPS -4.76%·Rev n/aQ1 22EPS +0.88%·Rev n/aQ4 21EPS -19.53%·Rev n/aQ3 21EPS +0.74%·Rev n/a⚠ consensus missing

USANA HEALTH SCIENCES INC USNA

Andrew Masuda — Director of Investor Relations

Kevin Guest — Chief Executive Officer

Chris Neamonitis — Analyst

Doug Hekking — Chief Financial Officer

Doug Lane — Analyst

Brent Neidig — Role not explicitly stated, likely senior management or market operations

Walter Noot — Chief Operations Officer

Linda Bolton Weiser — Analyst

+0.7%1d on move date−1.9% vs SPY3d+1.0%5d+0.8%

Research tier

Behavioral profile computed for 8 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more USNA calls or request research access.

More USNA calls Browse calls Request research access